Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Bratton Insider Profile
4 Followers
Douglas Bratton, Ten Percent Owner at Juno Therapeutics, holds 447.85K shares in Midwest Holding (Ticker: MDWT), holds 1.96M shares in Aquestive Therapeutics (Ticker: AQST), holds 10.08M shares in Denali Therapeutics (Ticker: DNLI).
Douglas Bratton Juno Therapeutics (JUNO)Ten Percent Owner
Juno Therapeutics (JUNO)
Ten Percent Owner
Ranked #95,572 out of 99,635 Corporate Insiders
Profitable Transactions
8 out of 13 Profitable Transactions
Average Return
-45.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Douglas Bratton holds in companies
Most Profitable Insider Trade
Stock:
Juno Therapeutics
(JUNO)
(JUNO)
Rating:Informative Buy
Date:Dec 18, 2014 - Dec 18, 2015
Return:+104.20%
The most profitable trade made by Douglas Bratton
Douglas Bratton's Trading History
Juno Therapeutics
Jul 17, 2017
―
Informative Sell
216.00M
$2.26B
Denali Therapeutics
Feb 17, 2021
Ten Percent Owner
Informative Sell
144.09M
$249.00M
Aquestive Therapeutics
Mar 16, 2021
Ten Percent Owner
Uninformative Sell
―
$8.94M
Midwest Holding
Jun 16, 2022
―
Uninformative Buy
―
$12.09M
List of latest transactions for each holding click on a transaction to see Douglas Bratton's performance on stock
You May Also Like
Douglas Bratton insider profile FAQ
What is the percentage of profitable transactions made by Douglas Bratton?
The percentage of profitable transactions made by Douglas Bratton is 62%.
What is the average return per transaction made by Douglas Bratton?
The average return per transaction made by Douglas Bratton is -45.10%.
What stocks does Douglas Bratton hold?
Douglas Bratton holds: JUNO, DNLI, AQST, MDWT stocks.
What was Douglas Bratton’s latest transaction?
Douglas Bratton latest transaction was an Uninformative Buy of ―.
What was Douglas Bratton's most profitable transaction?
Douglas Bratton’s most profitable transaction was an Informative Buy of JUNO stock on December 18, 2014. The return on the trade was 104.20%.
What is Douglas Bratton's role in Juno Therapeutics?
Douglas Bratton's role in Juno Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.